In this interview, we talk with Professor Tonia Vincent (Centre for Osteoarthritis Pathogenesis, University of Oxford, Oxford, UK) around how the therapeutic landscape in OA is changing.
This information is brought to you by Touch Medical Media and is not sponsored by, nor a part of, the American College of Rheumatology.
The presentation entitled ‘OA: New Horizons for Therapy.’ was given at the ACR Convergence, 3-9 November 2021.
- How are new delivery systems for osteoarthritis drugs opening new treatment possibilities? (0:16)
- What other novel approaches are in early stage clinical development? (1:50)
Disclosures: Tonia Vincent discloses ad hoc consultancy for Benevolent AI and academic support for STEpUP OA from: Novartis, Fidia, Galapagos, Biosplice, and Pfizer.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Filmed in coverage of the virtual ACR Convergence 2021.
Share this Video
Related Videos In Rheumatic Diseases
Juvenile Idiopathic Arthritis Awareness Week 2023 – Clare Jacklin, NRAS
Juvenile idiopathic arthritis awareness week (JIAAW) is taking place between 3-7 July to raise awareness and dispel misconceptions around JIA, this year’s theme is #BustingJIAMyths, you can take part by entering the ‘JIA Mythbuster’ quiz and joining the conversation on social media using #BustingJIAMyths and #JIAAW2023. touchIMMUNOLOGY were delighted to talk with CEO Clare Jacklin and support […]
Molecular phenotyping of giant cell arteritis patients based on the serum protein signature: Lisa Christ, EULAR 2023
There is a lack of biomarkers to profile phenotypes in giant cell arteritis (GCA) and predict potential complications. Serum protein profiling may identify molecular-based phenotypes and facilitate personalized medicine approaches. touchIMMUNOLOGY were delighted to speak with Dr Lisa Christ (Universitätsspital Bern Bern, Switzerland) about her study which investigated the serum protein signature of clinically defined GCA […]
Molecular Phenotyping of Giant Cell Arteritis: Lisa Christ, EULAR 2023
Giant cell arteritis (GCA) is a primary systemic vasculitis characterised by systemic inflammation and vascular insufficiency of large and medium blood vessels which may lead to end-organ damage in patients age 50 and older. touchIMMUNOLOGY were delighted to speak with Dr Lisa Christ (Universitätsspital Bern Bern, Switzerland) about the unmet needs in the pathogenesis of […]
Journal articles and more to your inbox
Get the latest clinical insights from touchIMMUNOLOGYSign me up!